• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
Subarachnoid haemorrhage impact could be ‘drastically reduced’

Subarachnoid haemorrhage impact could be ‘drastically reduced’

Researchers found 70% of related burden can be attributed to modifiable risk factors, such as high blood pressure and smoking.


Questions, answers, and embracing change

Questions, answers, and embracing change

The 2025 Practice Owners Conference ended with a call for GPs to keep their minds open to change as reforms sweep through the sector.


Full details of incoming CDM changes revealed

Full details of incoming CDM changes revealed

New MBS fees, transition arrangements and referral pathways have been unveiled. The RACGP President said he’s been left frustrated by the delay, but ‘at least we now have clarity’.


Treatment to slow early Alzheimer’s gets TGA approval

Treatment to slow early Alzheimer’s gets TGA approval

As donanemab becomes available to Australian patients, experts warn the health system must be ready for the significant shift it could bring.


TGA warns of ‘possible but rare’ RSV vaccines risk

TGA warns of ‘possible but rare’ RSV vaccines risk

Product Information for Arexvy and Abrysvo has been updated to reflect a low risk of Guillain-Barre Syndrome following vaccination.


Push for improved dementia education for GPs

Push for improved dementia education for GPs

One expert wants to boost ‘baseline knowledge’ of early detection, interventions and post-diagnostic care of the condition.


RSV vaccine approved for use in at-risk over-50s

RSV vaccine approved for use in at-risk over-50s

The new TGA approval allows access to the Arexvy vaccine for at-risk adults aged 50–59, expanding the previous indication.


Longer pollen season bringing more risk for asthma patients

Longer pollen season bringing more risk for asthma patients

Research shows the hay fever season is growing longer, and one expert says GPs are at the forefront of helping patients reduce complications.


Study examines whether RSV vaccine lasts ‘at least three winters’

Study examines whether RSV vaccine lasts ‘at least three winters’

The results of a randomised controlled trial indicate an RSV vaccine could offer protection against the virus over three seasons in over 60s.


Warning issued as measles cases surge

Warning issued as measles cases surge

GPs have once again been urged to take precautions, with 59 measles cases reported this year – more than the entirety of 2024.


  • Previous
  • 1
  • 2
  • 3
  • ...
  • Next
Pages: 1 of 40
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807